BIONET Corp. (TPEX:1784)

Market Cap	4.99B
Revenue (ttm)	1.22B
Net Income (ttm)	69.82M
Shares Out	50.31M
EPS (ttm)	1.38
PE Ratio	71.77
Forward PE	n/a
Dividend	1.42 (1.44%)
Ex-Dividend Date	Oct 3, 2025

Volume	158,758
Average Volume	486,960
Open	99.90
Previous Close	98.30
Day's Range	97.60 - 99.90
52-Week Range	62.40 - 109.50
Beta	0.51
RSI	56.71
Earnings Date	Nov 11, 2025

About BIONET

BIONET Corp. provides cell therapy services in Taiwan and internationally. The company offers stem cell banking services, including stem cell storage, mesenchymal stem cell storage, dental stem cell storage, adipose stem cell, and peripheral blood stem cells and immune cells; and genetic testing services. It also provides stem anti-aging and ANIKINE series products; and Exosome, a novel cell-free therapy. In addition, the company offers regenerative medicine, analytical testing, clinical and preclinical research, and commercialized cell-derived...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1989
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1784

Financial Performance

In 2024, BIONET's revenue was 1.22 billion, an increase of 8.40% compared to the previous year's 1.13 billion. Earnings were 83.70 million, an increase of 6.76%.